- Home
- COGT vs SPHR Comparison
COGT vs SPHR Comparison
Compare COGT & SPHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- SPHR
- Stock Information
- Founded
- COGT 2014
- SPHR 2020
- Country
- COGT United States
- SPHR United States
- Employees
- COGT N/A
- SPHR N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- SPHR Services-Misc. Amusement & Recreation
- Sector
- COGT Health Care
- SPHR Consumer Discretionary
- Exchange
- COGT Nasdaq
- SPHR Nasdaq
- Market Cap
- COGT 1.0B
- SPHR 1.1B
- IPO Year
- COGT 2018
- SPHR N/A
- Fundamental
- Price
- COGT $6.48
- SPHR $33.22
- Analyst Decision
- COGT Buy
- SPHR Buy
- Analyst Count
- COGT 7
- SPHR 9
- Target Price
- COGT $14.17
- SPHR $48.44
- AVG Volume (30 Days)
- COGT 1.0M
- SPHR 1.1M
- Earning Date
- COGT 05-06-2025
- SPHR 03-03-2025
- Dividend Yield
- COGT N/A
- SPHR N/A
- EPS Growth
- COGT N/A
- SPHR N/A
- EPS
- COGT N/A
- SPHR N/A
- Revenue
- COGT N/A
- SPHR $1,072,406,000.00
- Revenue This Year
- COGT N/A
- SPHR $6.49
- Revenue Next Year
- COGT N/A
- SPHR $7.53
- P/E Ratio
- COGT N/A
- SPHR N/A
- Revenue Growth
- COGT N/A
- SPHR 48.26
- 52 Week Low
- COGT $5.88
- SPHR $30.62
- 52 Week High
- COGT $12.61
- SPHR $50.88
- Technical
- Relative Strength Index (RSI)
- COGT 38.02
- SPHR 36.95
- Support Level
- COGT $6.31
- SPHR $32.11
- Resistance Level
- COGT $7.49
- SPHR $34.31
- Average True Range (ATR)
- COGT 0.43
- SPHR 1.32
- MACD
- COGT -0.04
- SPHR 0.46
- Stochastic Oscillator
- COGT 10.90
- SPHR 60.19
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.
About SPHR Sphere Entertainment Co.
Sphere Entertainment Co is a live entertainment and media company. The firm creates, writes, casts, produces, and tours shows and events. The group has two reportable segments which includeSphere and MSG Networks. Sphere is a next-generation entertainment medium, and MSG Networks operates two regional sports and entertainment networks, as well as a direct-to-consumer (DTC) and authenticated streaming product.